Pharmaceutical Hot Melt Extrusion Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2026

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pharmaceutical Hot Melt Extrusion Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.4.4. Trends
4.5. Global Pharmaceutical Hot Melt Extrusion Analysis and Forecasts, 2019–2026
4.5.1. Market Volume Projections, 2019–2026
4.5.3. Market Revenue Projections (US$ Mn)
4.6. Pharmaceutical Hot Melt Extrusion - Global Supply Demand Scenario
4.7. Porter’s Five Force Analysis
4.8. Value Chain Analysis
4.9. Market Outlook
4.10. Technology Assessment Analysis
4.11. cGMP Regulations
4.12. CMO/Pharma Company End-User Licensing

5. Global Pharmaceutical Hot Melt Extrusion Analysis and Forecasts, By Product
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value and Volume Forecast By Product, 2019–2026
5.4.1. Twin Screw Extruders
5.4.2. Single Screw Extruder
5.4.3. Laboratory Extruder
5.4.4. RAM Extruder
5.5. Product Comparison Matrix
5.6. Market Attractiveness By Product

6. Global Pharmaceutical Hot Melt Extrusion Analysis and Forecasts, By End User
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value and Volume Forecast By End User, 2019–2026
6.3.1. Research Laboratory
6.3.2. CMO
6.3.3. Pharma Companies
6.4. End User Comparison Matrix
6.5. Market Attractiveness By End User

7. Global Pharmaceutical Hot Melt Extrusion Analysis and Forecasts, By Region
7.1. Key Findings
7.2. Policies and Regulations
7.3. Market Value and Volume Forecast By Region
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Latin America
7.3.5. Middle East and Africa
7.4. Market Attractiveness By Country/Region

8. North America Pharmaceutical Hot Melt Extrusion Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.1.2. Policies and Regulations
8.2. Market Value and Volume Forecast By Product, 2019–2026
8.2.1. Twin Screw Extruders
8.2.2. Single Screw Extruder
8.2.3. Laboratory Extruder
8.2.4. RAM Extruder
8.3. Market Value and Volume Forecast By End User, 2019–2026
8.3.1. Research Laboratory
8.3.2. CMO
8.3.3. Pharma Companies
8.4. Market Value and Volume Forecast By Country, 2019–2026
8.4.1. US
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Product
8.5.2. By End User
8.5.3. By Country

9. Europe Pharmaceutical Hot Melt Extrusion Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.1.2. Policies and Regulations
9.2. Market Value and Volume Forecast By Product, 2019–2026
9.2.1. Twin Screw Extruders
9.2.2. Single Screw Extruder
9.2.3. Laboratory Extruder
9.2.4. RAM Extruder
9.3. Market Value and Volume Forecast By End User, 2019–2026
9.3.1. Research Laboratory
9.3.2. CMO
9.3.3. Pharma Companies
9.4. Market Value and Volume Forecast By Country, 2019–2026
9.4.1. Germany
9.4.2. France
9.4.3. Italy
9.4.4. U.K.
9.4.5. Spain
9.4.6. Rest of Europe
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End User
9.5.3. By Country

10. Asia Pacific Pharmaceutical Hot Melt Extrusion Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.1.2. Policies and Regulations
10.2. Market Value and Volume Forecast By Product, 2019–2026
10.2.1. Twin Screw Extruders
10.2.2. Single Screw Extruder
10.2.3. Laboratory Extruder
10.2.4. RAM Extruder
10.3. Market Value and Volume Forecast By End User, 2019–2026
10.3.1. Research Laboratory
10.3.2. CMO
10.3.3. Pharma Companies
10.4. Market Value and Volume Forecast By Country, 2019–2026
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia
10.4.5. New Zealand
10.4.6. Rest of APAC
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End User
10.5.3. By Country

11. Latin America Pharmaceutical Hot Melt Extrusion Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.1.2. Policies and Regulations
11.2. Market Value and Volume Forecast By Product, 2019–2026
11.2.1. Twin Screw Extruders
11.2.2. Single Screw Extruder
11.2.3. Laboratory Extruder
11.2.4. RAM Extruder
11.3. Market Value and Volume Forecast By End User, 2019–2026
11.3.1. Research Laboratory
11.3.2. CMO
11.3.3. Pharma Companies
11.4. Market Value and Volume Forecast By Country, 2019–2026
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End User
11.5.3. By Country

12. Middle East and Africa Pharmaceutical Hot Melt Extrusion Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.1.2. Policies and Regulations
12.2. Market Value and Volume Forecast By Product, 2019–2026
12.2.1. Twin Screw Extruders
12.2.2. Single Screw Extruder
12.2.3. Laboratory Extruder
12.2.4. RAM Extruder
12.3. Market Value and Volume Forecast By End User, 2019–2026
12.3.1. Research Laboratory
12.3.2. CMO
12.3.3. Pharma Companies
12.4. Market Value and Volume Forecast By Country, 2019–2026
12.4.1. Saudi Arabia
12.4.2. UAE
12.4.3. South Africa
12.4.4. Rest of MEA
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End User
12.5.3. By Country

13. Competition Landscape
13.1. Market Share Analysis By Company (2015)
13.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
13.2.1. Baker Perkins Limited
13.2.1.1. Overview
13.2.1.2. Financials
13.2.1.3. Recent Developments
13.2.1.4. Strategy
13.2.2. Coperion GmbH
13.2.2.1. Overview
13.2.2.2. Financials
13.2.2.3. Recent Developments
13.2.2.4. Strategy
13.2.3. Xtrutech Ltd
13.2.3.1. Overview
13.2.3.2. Financials
13.2.3.3. Recent Developments
13.2.3.4. Strategy
13.2.4. Gabler GmbH & Co. KG
13.2.4.1. Overview
13.2.4.2. Financials
13.2.4.3. Recent Developments
13.2.4.4. Strategy
13.2.5. Leistritz AG
13.2.5.1. Overview
13.2.5.2. Financials
13.2.5.3. Recent Developments
13.2.5.4. Strategy
13.2.6. Milacron Holdings Corp.
13.2.6.1. Overview
13.2.6.2. Financials
13.2.6.3. Recent Developments
13.2.6.4. Strategy
13.2.7. Thermo Fisher Scientific, Inc.
13.2.7.1. Overview
13.2.7.2. Financials
13.2.7.3. Recent Developments
13.2.7.4. Strategy

14. Key Takeaways